Phio Pharmaceuticals to present PH-762 cancer study results at dermatology meeting
Go back to Phio Pharmaceuticals to present PH-762 cancer study results at dermatology meeting| (NASDAQ: PHIO) | Delayed: 1.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.06 | 52 Week High | $ | |||
| Open | $1.06 | 52 Week Low | $ | |||
| Day High | $1.06 | P/E | N/A | |||
| Day Low | $1.06 | EPS | $ | |||
| Volume | 7,486 | |||||
